Photo of Craig A. Goldman
R United States House · District 12 · Texas On the 2026 ballot

Rep. Craig A. Goldman

Compare
Total votes
669
all sessions
Attendance
100%
3 missed
Higher than 85% of chamber peers
With party
98%
of cast votes
Higher than 79% of chamber peers
Bipartisan score
1%
crosses aisle rarely
Lower than 80% of chamber peers
Sponsored
249
bills & resolutions
Near the chamber average
Committees
4
assignments
249 bills and resolutions

Sponsored bills

Total
249
Primary
16
Co-sponsor
233
This page
249
matching current filters
Co-sponsor HR 1548
In committee · United States House · Co-sponsor
Leveling the Playing Field 2.0 Act

Maddy summaryHR 1548, the "Leveling the Playing Field 2.0 Act," amends U.S. trade laws to strengthen enforcement of antidumping and countervailing duty regulations. The bill creates new rules for handling multiple investigations on the same merchandise (successive investigations), addresses market distortions in foreign countries that affect production costs, and improves mechanisms to prevent companies from circumventing existing duties. It also establishes procedures for investigating currency undervaluation as a form of subsidy and strengthens requirements for importers to certify compliance with trade laws. These changes primarily affect U.S. importers of foreign goods, foreign exporters, and the Department of Commerce, which administers these trade enforcement mechanisms.

In committee Feb 24, 2025 1 co-sponsor
Co-sponsor HR 1521
In committee · United States House · Co-sponsor
DOC Access Act of 2025

Dentist and Optometric Care Access Act of 2025 or the DOC Access Act of 20 25 This bill prohibits private health insurance plans from setting rates for items and services, except for dental cleanings, provided by a doctor of optometry, of dental surgery, or of dental medicine (or an employer of such a doctor) for which the plan does not pay a substantial amount. Additionally, an agreement between a plan and such a doctor for limited scope dental or vision benefits may last longer than two years only with the prior acceptance of the doctor for each term extension. Plans also may not restrict such a doctor's choice of laboratories or suppliers. Such doctors may elect to waive the application of the payment amount and choice of laboratories provisions of this bill. The bill does not supersede state laws regarding health insurers and dental or vision benefit plans.

In committee Feb 24, 2025 1 co-sponsor
Co-sponsor HR 1502
In committee · United States House · Co-sponsor
North Platte Canteen Congressional Gold Medal Act

Maddy summaryHR 1502 authorizes the creation of a Congressional Gold Medal to honor the volunteers and communities (primarily from Nebraska, Colorado, and Kansas) who supported the North Platte Canteen during World War II. The bill directs the Treasury Secretary to design and strike the medal, which will be presented to the individuals who contributed to the canteen’s operations and then permanently displayed at the Lincoln County Historical Museum in North Platte, Nebraska. It also permits the sale of bronze duplicates to cover production costs, with proceeds going to the U.S. Mint. This is a commemorative measure recognizing historical service, not a policy change affecting current laws or programs.

In committee Feb 21, 2025 1 co-sponsor
Co-sponsor HR 1492
In committee · United States House · Co-sponsor
To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.

Maddy summaryHR 1492 amends the Social Security Act to extend the negotiation period for standard drug manufacturers under the federal drug pricing program. Specifically, it changes the timeframe from 7 years to 11 years for small-molecule drugs (like traditional pills) to negotiate prices with the government, aligning it with the existing 12-year period for complex biologic drugs (like insulin or monoclonal antibodies). This adjustment directly affects pharmaceutical companies that produce small-molecule drugs, giving them a longer window to negotiate pricing terms. The bill makes this change effective as if it had been part of the 2022 law that established the program.

In committee Feb 21, 2025 1 co-sponsor
Co-sponsor HR 1463
In committee · United States House · Co-sponsor
To prohibit the use of Federal funds to implement, administer, or enforce a final rule of the Food and Drug Administration relating to "Medical Devices; Laboratory Developed Tests", and for other purposes.

Maddy summaryHR 1463 prohibits the use of federal funds to implement, administer, or enforce a specific FDA rule about medical devices known as "laboratory developed tests" (LDTs), published in the Federal Register on May 6, 2024 (89 Fed. Reg. 37286). The bill directly affects the Food and Drug Administration (FDA), preventing it from using taxpayer money to carry out this regulation. Its key mechanism is a straightforward funding ban on the specified rule and any substantially similar future rule. This is a procedural restriction focused solely on blocking financial support for the FDA's LDT regulatory approach.

In committee Feb 21, 2025 1 co-sponsor
Co-sponsor HR 1415
In committee · United States House · Co-sponsor
No IRIS Act of 2025

Maddy summaryThe No IRIS Act of 2025 (HR 1415) prohibits the Environmental Protection Agency (EPA) from using scientific assessments generated by its Integrated Risk Information System (IRIS) program to develop environmental regulations, enforce laws, issue permits, or inform air toxics mapping tools. This bill directly restricts the EPA’s regulatory process by banning IRIS data from key decision-making steps in environmental rulemaking. The law requires the EPA to rely on alternative scientific data for these purposes, without altering the IRIS program itself. It does not change existing EPA authority but limits how specific assessments may be applied in regulatory actions.

In committee Feb 18, 2025 1 co-sponsor
Co-sponsor HR 1367
In committee Feb 14, 2025 1 co-sponsor
Co-sponsor HCONRES 12
In committee · United States House · Co-sponsor
Supporting the Local Radio Freedom Act.

This concurrent resolution declares that Congress should not impose any new performance fee, tax, royalty, or other charge relating to the public performance of sound recordings on a local radio station for broadcasting sound recordings over the air, or on any business for such public performance of sound recordings.

In committee Feb 13, 2025 1 co-sponsor
Co-sponsor HR 1301
In committee · United States House · Co-sponsor
Death Tax Repeal Act

Maddy summaryHR 1301, the Death Tax Repeal Act, would eliminate the federal estate tax and generation-skipping transfer tax for estates of individuals dying on or after its enactment date. It directly affects individuals inheriting significant assets, as it removes taxes on estates exceeding $10 million (adjusted for inflation) and repeals taxes on large transfers between generations. The bill modifies the gift tax by establishing a $10 million lifetime exemption with annual inflation adjustments, replacing previous tax brackets. It applies to estates, gifts, and transfers occurring on or after the bill's effective date.

In committee Feb 13, 2025 1 co-sponsor
Co-sponsor HR 1340
In committee · United States House · Co-sponsor
More Homes on the Market Act

More Homes on the Market Act This bill increases the amount of gain from the sale of a principal residence that an individual may exclude from gross income (for federal tax purposes). Under the bill, an individual may exclude from gross income gain from the sale of a principal residence of up to $500,000 (currently $250,000), and taxpayers who are married and file a joint federal income tax return may exclude up to $1 million (currently $500.000). The bill also requires these amounts to be adjusted annually for inflation.

In committee Feb 13, 2025 1 co-sponsor
Showing 191 to 200 of 249 bills
Previous 1 … 19 20 21 … 25 Next